FDA Flavored ENDS PMTA Guide 2026: What the Draft Changes Mean for You
Published September 25, 2026 | 12 min read
Breaking: FDA Reshapes the Flavored Vape Landscape
BREAKING — On March 11, 2026, the FDA published a draft guidance that fundamentally changes how flavored e-cigarette products will be evaluated under the PMTA process. The guidance (Docket No. FDA-2026-D-1817, 91 Fed. Reg. 11,980) creates a two-tier flavor risk system, and just weeks later, the FDA authorized the first-ever non-tobacco, non-menthol flavored ENDS products — Glas G2 Gold (mango) and Sapphire (blueberry) — using device access restriction (DAR) technology. Twenty-one state attorneys general are fighting to scrap the whole framework.
What This Means for You: The Impact Summary
The FDA's draft guidance, published March 11, 2026, represents the most significant shift in flavored e-cigarette regulation since the PMTA process began. For the first time, the FDA has created a formal framework that distinguishes between "lower-risk" flavors (menthol, mint, coffee, tea, spices, wintergreen) and "higher-risk" flavors (fruit, candy, dessert) — and sets different evidentiary standards for each. Then on May 5, the FDA authorized the Glas G2 device with Gold (mango) and Sapphire (blueberry) pods — the first non-tobacco, non-menthol flavored ENDS products ever approved, made possible by built-in device access restriction (DAR) technology that ties the device to a verified adult user's smartphone.
For the complete list of all 48 FDA-authorized products, see our complete FDA-authorized vape product list. For how the FDA's broader enforcement crackdown affects the market, read our FDA seize-and-destroy law guide.
The Two-Tier Flavor System Explained
The core innovation of the March 2026 draft guidance is a graduated, risk-proportionate evaluation framework. Instead of treating all non-tobacco flavors the same, the FDA categorizes them into two tiers based on perceived youth-appeal risk. The tier determines how much evidence an applicant must provide that adult benefits (switching from combustible cigarettes) outweigh youth initiation risks under the "appropriate for the protection of the public health" (APPH) standard.
| Tier | Flavors | Evidentiary Burden | Youth-Risk Assessment |
|---|---|---|---|
| Lower-Risk Tier | Menthol, mint, coffee, tea, spices, wintergreen | Requires a "relatively small" adult-benefit showing — limited switching from combustibles may suffice | FDA considers these less appealing to youth based on usage data |
| Higher-Risk Tier | Fruit, candy, dessert | Requires a much stronger showing — adult benefits must substantially outweigh youth risks | Heavy emphasis on preventing youth initiation; stricter scrutiny |
Key distinction: The guidance does not ban any flavor. It does not create an automatic prohibition. Instead, it clarifies the evidentiary burden — how much proof of adult benefit is needed — based on the flavor's youth-risk profile. A fruit-flavored product can still be authorized, but the manufacturer must provide stronger evidence than a menthol-flavored applicant.
The Glas G2 Precedent: How DAR Technology Changed Everything
On May 5, 2026, the FDA authorized four Glas G2 closed-pod ENDS products. Two of them — Gold (mango) and Sapphire (blueberry) — became the first non-tobacco, non-menthol flavored ENDS products ever authorized through the PMTA process. This was not a random decision. The Glas G2 device includes a built-in Device Access Restriction (DAR) system that creates a technological barrier to youth access.
How DAR Technology Works
| Step | Requirement | What Happens |
|---|---|---|
| 1 | Government ID verification | User submits a government-issued ID for age and identity verification at registration |
| 2 | Bluetooth smartphone pairing | Device pairs with the verified user's smartphone via Bluetooth |
| 3 | Phone tethering | Device remains non-functional if separated from the registered user's phone |
| 4 | Random biometric check-ins | Periodic biometric verification confirms the registered user is the person using the device |
"FDA found that the DAR technology, combined with FDA-required marketing restrictions, was expected to effectively mitigate youth use. Most adults aged 21 and older successfully completed age verification and found the device-use instructions and age-verification software easy to understand and activate, while youth and young adults could not."
— FDA press release, May 5, 2026
The Glas G2 authorization creates a precedent that could reshape the industry: flavored ENDS can be authorized if the device itself prevents youth access. However, the draft guidance takes a more cautious stance — suggesting that DAR may be "unlikely to be sufficient on its own" for flavors the FDA considers particularly appealing to youth (fruit, candy, dessert). This creates a regulatory paradox: the only non-tob flavored products authorized so far used DAR, but the guidance suggests DAR alone may not be enough for the highest-risk flavors.
The 48 Authorized Products: Flavor Breakdown
As of August 28, 2026, the FDA has authorized 48 ENDS products. Here's the complete breakdown by flavor category:
| Category | Count | Examples | FDA Status |
|---|---|---|---|
| Tobacco-flavored | 21 | JUUL Virginia Tobacco, NJOY Rich Tobacco, Vuse Golden Tobacco, Logic Tobacco, Glas Blonde Tobacco | |
| Menthol-flavored | 9 | JUUL Menthol, NJOY Menthol, Glas Fresh Menthol & Classic Menthol, Vuse Menthol | |
| Non-tobacco/non-menthol | 2 | Glas G2 Gold (mango), Glas G2 Sapphire (blueberry) | |
| Device-only | 16 | JUUL Device, JUUL2 Device, NJOY ACE Device, Vuse devices, Logic devices, Glas G2 Device |
The 2 non-tob/non-menthol products represent just 4.2% of the authorized list — but they represent 100% of the FDA's flavored ENDS precedent. Every future flavored PMTA application will be evaluated against the framework the March 2026 guidance establishes.
Timeline: How We Got Here
FDA announces draft guidance availability on flavored ENDS PMTA evaluations
Draft guidance published in Federal Register (91 Fed. Reg. 11,980, Docket No. FDA-2026-D-1817)
Public comment period opens
FDA authorizes four Glas G2 ENDS products — including Gold (mango) and Sapphire (blueberry), the first non-tobacco/non-menthol flavors authorized through PMTA. Authorization hinged on DAR technology.
FDA issues separate enforcement priorities guidance for unauthorized ENDS and nicotine pouch products
Comment period closes. Bipartisan coalition of 21 state attorneys general submits opposition letter urging FDA to abandon the draft guidance.
Draft guidance remains active. No final guidance publication date has been announced.
The 21 State AG Opposition
On May 11, 2026, a bipartisan coalition of 21 state attorneys general submitted a comment letter urging the FDA to abandon the draft guidance entirely. The coalition was led by California AG Rob Bonta and New Jersey AG Jennifer Davenport.
The 21 Opposing States
California, Arizona, Connecticut, Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, Minnesota, Nebraska, New Jersey, New Mexico, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, South Dakota, Vermont, and Wisconsin.
"The relative youth appeal of various flavors can change over time, including in response to market trends. The FDA's distinction between 'lower risk' flavors is fundamentally flawed."
— 21 State AG Coalition Letter, May 11, 2026
Key Arguments from the Opposition
| Argument | AG Position | FDA Response |
|---|---|---|
| "Lower-risk" flavors are flawed | Youth appeal shifts with trends; menthol/mint can become high-appeal | Based on current NYTS usage data showing fruit/candy preferred by youth |
| All flavors appeal to youth | Flavored products of all kinds are favored by youth over unflavored tobacco | Tiered approach reflects graduated risk, not a binary ban |
| Enforcement too lenient | May 8 enforcement guidance is too permissive on unauthorized products with pending PMTAs | Non-prioritized enforcement ≠ authorization; products remain subject to action |
| Draft should be scrapped | Urges FDA to abandon the guidance entirely | Draft remains active; FDA reviewing comments |
Supreme Court: FDA v. Wages and White Lion Investments
The legal landscape shifted further when the Supreme Court decided FDA v. Wages and White Lion Investments, upholding the FDA's comparative efficacy framework for evaluating flavored ENDS PMTAs. This means the FDA's approach — comparing a new flavored product's youth risk against its adult-switching benefit relative to existing authorized products — was upheld as legally valid. This closes off a major legal challenge avenue for manufacturers seeking to overturn PMTA denials in court.
For context on how the FDA's enforcement has escalated, see our seize-and-destroy law guide covering Operation Red Mist (18M units seized, $175M in product).
Enforcement Priorities: The May 8 Guidance
Separately from the flavored ENDS draft, on May 8, 2026, the FDA issued an enforcement priorities guidance for unauthorized ENDS and nicotine pouch products. This guidance states that the FDA does not intend to prioritize enforcement against certain unauthorized ENDS products, including products with pending PMTAs that have been accepted and filed — unless they have "presumptively underage-appealing elements."
Important distinction: Non-prioritized enforcement does NOT mean a product is authorized. Unauthorized ENDS products remain subject to enforcement actions at any time. Retailers and consumers should rely only on the FDA's authorized product list, not on enforcement-discretion status. See our state flavor ban guide for state-level enforcement that may be stricter than federal policy.
US vs. UK: Divergent Regulatory Paths
The US and UK have taken dramatically different approaches to flavored ENDS regulation:
| Policy Dimension | United States | United Kingdom |
|---|---|---|
| Flavor regulation | Two-tier PMTA risk framework (March 2026 draft). No automatic flavor ban. 48 authorized products, 2 non-tob flavored. | Consultation on restricting flavor descriptors to single recognized flavors (e.g., "Apple"). Names referencing confectionery, desserts, or alcohol to be banned. |
| Disposable vapes | No federal ban. Unauthorized disposables subject to enforcement but widely available through gray market. | Banned since June 1, 2025. All vapes must be rechargeable and refillable. |
| Packaging | No federal packaging restrictions beyond PMTA-related marketing limitations. | Proposed plain white packaging, limited imagery/branding, device colors restricted to white, black, or grey. |
| Taxation | No federal vape tax. State-level taxes vary widely. | Vaping Products Duty scheduled for October 1, 2026, with a one-off tobacco duty increase. |
| Age-gating technology | DAR technology (Glas G2) accepted as youth-prevention pathway for PMTA authorization. | No DAR equivalent. Focus on retail enforcement and packaging restrictions. |
| Youth prevention | PMTA process + DAR technology + marketing restrictions + enforcement priorities | MHRA notification + packaging rules + disposable ban + retail licensing |
For our full UK vs US comparison, see our complete state flavor ban guide which includes international regulatory comparisons.
Methodology
Research period: March – September 2026 | Sources: Federal Register (91 Fed. Reg. 11,980), FDA.gov press releases, FDA authorized product list (updated Aug 28, 2026), state AG coalition press releases, industry regulatory analysis, UK Parliament records | Analysis approach: Primary source document review of the draft guidance, FDA press releases, and public comment submissions. Cross-referenced with the FDA's authorized ENDS product list and enforcement guidance.
Limitations of This Analysis
- Draft status: The March 2026 guidance is a draft. The FDA may revise the final guidance based on public comments. No final publication date has been announced.
- Flavor taxonomy: The FDA does not publish an official flavor taxonomy for authorized products. Flavor categorizations are inferred from product names, FDA press releases, and industry reporting.
- DAR precedent limited: The Glas G2 is the only DAR-authorized product. Whether DAR will be sufficient for other manufacturers' products remains uncertain — the draft guidance itself is cautious.
- Enforcement gap: The FDA's enforcement priorities guidance creates a gray area where unauthorized products with pending PMTAs may be sold without prioritized enforcement. This is not the same as authorization.
- No final guidance: As of September 2026, the draft remains under FDA review. All analysis is based on the draft, which may change.
What This Means for You: Impact by Stakeholder
For Adult Vapers
The draft guidance does not change what you can legally buy today. Only 48 products are FDA-authorized. If the guidance is finalized, it may expand access to lower-risk flavors (menthol, mint, coffee, tea) through clearer PMTA pathways, while higher-risk flavors (fruit, candy, dessert) will remain harder to bring to market legally. The Glas G2 precedent suggests that future flavored products may require DAR-like age-gating technology.
For Retailers
The May 8 enforcement guidance creates a gray area: unauthorized products with pending PMTAs may be sold without prioritized enforcement — unless they have "presumptively underage-appealing elements." However, this is enforcement discretion, not authorization. Retailers should stock from the 48 authorized products and check our retailer compliance checklist for full guidance.
For Manufacturers
The draft guidance provides clearer evidentiary expectations but imposes stricter scrutiny on higher-risk flavors. Manufacturers relying on DAR technology should note the draft's cautious stance — DAR may not be sufficient alone for the highest-risk flavors. The Supreme Court's Wages and White Lion decision closes off legal challenges to the comparative efficacy framework. The path forward requires substantial adult-switching evidence combined with effective youth-access prevention.
Consumer Compliance Checklist
How to navigate the flavored ENDS regulatory landscape:
- Check if your product is on the FDA's 48 authorized products list
- Understand that "PMTA pending" ≠ authorized — enforcement discretion is temporary
- Know your state's flavor ban laws — 14+ states have flavor restrictions stricter than federal policy
- If using a flavored product, verify it came from a legitimate retailer, not the gray market
- Watch for DAR-equipped devices (like Glas G2) — these may become the standard for flavored ENDS
- Report unauthorized products to the FDA via their tobacco product violation reporting system
- Follow the FDA's authorized product list updates at FDA.gov for the latest changes
User Personas: How the Draft Guidance Affects Different Vapers
Persona AThe Switching Smoker Seeking Flavors
Profile: Adult smoker (21+) trying to switch from cigarettes. Fruit or menthol flavors help them stay off combustibles. Worried about losing flavor access.
Impact: The draft guidance actually expands potential flavor access by creating a clearer PMTA pathway for lower-risk flavors. If the guidance is finalized, expect more menthol, mint, and coffee-flavored authorized products. Fruit flavors will be harder but not impossible — the Glas G2 shows DAR technology can work. Look for DAR-equipped devices from other manufacturers in 2027.
Persona BThe Retailer Navigating Compliance
Profile: Vape shop owner. Needs to know what's legal to stock and sell. Confused about enforcement priorities vs. authorization.
Impact: The May 8 enforcement guidance creates a gray area, but the safest strategy is to stock only from the 48 authorized products. The draft guidance doesn't change your current obligations — unauthorized products are still subject to enforcement. Use our retailer compliance checklist and verify every SKU against the FDA's authorized list. State laws may be stricter — check our state flavor ban guide.
Persona CThe Tobacco-Flavored Purist
Profile: Vapes tobacco-flavored e-liquid exclusively. Believes flavors other than tobacco attract youth and shouldn't be sold.
Impact: The draft guidance validates this concern — the two-tier system acknowledges that fruit/candy flavors pose higher youth risk. However, it doesn't go as far as you might want: the Glas G2 authorization proves that even fruit flavors can be authorized with sufficient youth-prevention technology. The framework is risk-proportionate, not a ban. See our tobacco e-liquid brand ranking for authorized tobacco options.
Persona DThe Industry Observer
Profile: Works in the vape industry (manufacturer, distributor, or regulatory affairs). Needs to understand the PMTA pathway for flavored products.
Impact: The draft guidance + Glas G2 authorization + Supreme Court decision = a clearer but tougher regulatory landscape. For lower-risk flavors, the evidentiary burden is lower but still substantial. For higher-risk flavors, DAR technology appears necessary but may not be sufficient alone. The Wages and White Lion decision means legal challenges to PMTA denials are less likely to succeed. The path forward: invest in robust adult-switching studies and DAR-equivalent youth prevention technology.
Persona EThe Public Health Advocate
Profile: Concerned about youth vaping rates. Supports strict regulation or bans on flavored ENDS. Aligned with the 21 AG coalition.
Impact: The 21 AG opposition reflects your concerns — the "lower-risk" tier may be too permissive, and youth appeal can shift. The draft guidance does not go far enough from this perspective. However, the May 8 enforcement guidance's non-prioritization of certain unauthorized products is a concern. Advocacy should focus on: (1) urging FDA to scrap the lower-risk tier, (2) pushing for stricter enforcement against all unauthorized flavored products, and (3) supporting state-level flavor bans that go beyond federal policy.
FAQ
What is the FDA flavored ENDS PMTA draft guidance?
The FDA's March 2026 draft guidance (Docket No. FDA-2026-D-1817) establishes a two-tier risk-proportionate framework for evaluating flavored ENDS PMTA applications. Lower-risk flavors (menthol, mint, coffee, tea, spices, wintergreen) require less evidence of adult benefit, while higher-risk flavors (fruit, candy, dessert) face a stricter evidentiary burden. The guidance does not ban any flavor but clarifies how FDA weighs youth appeal against adult-switching benefits.
How many flavored ENDS products has the FDA authorized?
As of August 2026, the FDA has authorized 48 ENDS products total. Of these, 21 are tobacco-flavored, 9 are menthol-flavored, 2 are non-tobacco/non-menthol (Glas G2 Gold mango and Sapphire blueberry, authorized May 5, 2026), and 16 are device-only products. The Glas G2 Gold and Sapphire were the first non-tob flavored ENDS products ever authorized through PMTA.
What is the Glas G2 authorization and why does it matter?
On May 5, 2026, the FDA authorized four Glas G2 closed-pod ENDS products, including Gold (mango) and Sapphire (blueberry) — the first non-tobacco, non-menthol flavored ENDS products authorized through PMTA. The authorization hinged on the Glas G2 device's built-in Device Access Restriction (DAR) technology, which requires government ID verification, Bluetooth smartphone pairing, biometric check-ins, and renders the device inoperable if separated from the registered user's phone.
Why do 21 state attorneys general oppose the FDA draft guidance?
A bipartisan coalition of 21 state attorneys general (led by California and New Jersey) submitted a comment letter on May 11, 2026 urging the FDA to abandon the draft guidance. They argue that the "lower-risk" flavor categorization is fundamentally flawed because youth appeal can shift with market trends, and that all flavored products are preferred by youth over unflavored tobacco. They also criticized the FDA's May 8 enforcement guidance for being too lenient on unauthorized products with pending applications.
What is DAR technology and how does it work?
Device Access Restriction (DAR) technology is a youth-prevention system built into the Glas G2 device. It requires: (1) age and identity verification using a government-issued ID, (2) Bluetooth pairing with a smartphone, (3) the device remains non-functional if separated from the verified user's phone, and (4) random biometric check-ins to confirm the registered user is the person using the device. FDA found that most adults 21+ could complete verification easily while youth could not.
Does the draft guidance ban fruit and candy vape flavors?
No. The draft guidance does not ban any specific flavor. It creates a two-tier system where fruit, candy, and dessert flavors face a higher evidentiary burden — manufacturers must show stronger evidence that adult benefits outweigh youth risks. Menthol, mint, coffee, tea, and spices are categorized as lower-risk and require less evidence. The guidance clarifies evaluation criteria but does not impose automatic bans.
What is the timeline for the FDA flavored ENDS PMTA guidance?
March 9, 2026: FDA announces draft guidance. March 11: Published in Federal Register. April 17: Comment period opens. May 5: FDA authorizes Glas G2 products. May 8: FDA issues enforcement priorities guidance. May 11: Comment period closes with 21 AG opposition. As of September 2026, the draft remains active with no announced date for final guidance.
How does the US flavored ENDS regulation compare to the UK?
The US has authorized 48 ENDS products through PMTA and created a risk-proportionate flavor framework. The UK banned disposable vapes (June 2025), is implementing the Vaping Products Duty tax (October 2026), proposed plain white packaging with restricted device colors, and is restricting flavor descriptors to single recognized flavors (no confectionary or dessert names). The UK is more restrictive on packaging and device types while the US focuses on PMTA authorization pathways.
Can I still buy flavored vapes while the draft guidance is pending?
The draft guidance does not change what is legally sold today. Only 48 FDA-authorized products are on the market legally. However, many unauthorized flavored ENDS products remain available through gray market channels. The FDA's May 8 enforcement guidance states it will not prioritize enforcement against certain unauthorized products with pending PMTAs, unless they have presumptively underage-appealing elements.
What does the Supreme Court decision mean for flavored ENDS?
In FDA v. Wages and White Lion Investments, the Supreme Court upheld the FDA's comparative efficacy framework for evaluating flavored ENDS PMTAs. This means the FDA's approach — comparing a new flavored product's youth risk against its adult-switching benefit relative to existing authorized products — was upheld as legally valid, closing off a major legal challenge avenue for manufacturers seeking to overturn PMTA denials.
We Want to Hear From You
Will the two-tier flavor system help or hurt adult vapers?
The FDA's draft guidance creates a pathway for some flavored products while raising the bar for others. Do you think the "lower-risk" flavor tier is fair? Will DAR technology like the Glas G2 become the industry standard? Should the 21 AGs' opposition scrap the whole framework?
Join the conversation: Share your perspective on Reddit at r/electronic_cigarette. Your input helps shape how regulators and the industry understand the real-world impact of these policies.
Sources & References
- Federal Register. "Flavored ENDS Premarket Applications — Considerations Related to Youth Risk; Draft Guidance for Industry; Availability." 91 Fed. Reg. 11,980, March 11, 2026. Link
- FDA. "FDA Expands Market Access, Authorizes New ENDS Products." May 5, 2026. Link
- FDA. "E-Cigarettes, Vapes and Other ENDS Authorized by the FDA." Updated August 28, 2026. Link
- FDA. "FDA Issues Guidance on Enforcement Priorities for Unauthorized ENDS and Nicotine Pouch Products." May 8, 2026. Link
- California AG Rob Bonta. "Attorney General Bonta Urges FDA to Reverse Guidance Easing Sales of Flavored E-Cigarettes." May 12, 2026. Link
- New Jersey AG Jennifer Davenport. "AG Davenport Urges Trump Administration Not to Open the Door to Addictive Flavored Vapes." May 13, 2026. Link
- FDAatty. "Flavored E-Cigarette PMTAs in 2026: What FDA's New Draft Guidance Actually Changes." May 6, 2026. Link
- The Continuum of Risk. "FDA Authorizes Glas Flavored ENDS Products, Opening an Age-Gating Pathway for Flavors." May 7, 2026. Link
- AAFP Comment Letter. Docket No. FDA-2026-D-1817. May 11, 2026. Link
- Coalition of Public Health Organizations. Comments on Flavored ENDS Draft Guidance. May 11, 2026. Link
- UK Parliament. "Electronic Cigarettes: Regulation." Written Question, June 11, 2026. Link
- UK Parliament. "Tobacco and Vapes Consultation on Packaging." Written Statement, July 13, 2026. Link
Continue Reading
Stay Informed
Get Regulatory Updates & Vape News
Join our newsletter for weekly FDA regulatory updates, new PMTA authorizations, and analysis of how policy changes affect your vaping choices — delivered weekly, no spam.
Subscribe FreeFTC Disclosure: Vape Insider is an independent media publication. We do not sell vape products and do not accept payment from manufacturers for regulatory coverage. This article is based on primary source document review of FDA guidance, Federal Register publications, and public comment submissions. Some links may be affiliate links — see our full disclosure policy.
Legal Disclaimer: This article is for informational purposes only and does not constitute legal advice. The FDA's draft guidance is not final and may change. Only the 48 products on the FDA's authorized list are legally authorized for sale. Unauthorized ENDS products remain subject to enforcement. Consult a regulatory attorney for compliance guidance specific to your business.
FDA Notice: The draft guidance (Docket No. FDA-2026-D-1817) is a draft and has not been finalized. This article analyzes the draft as published on March 11, 2026. The FDA may revise the final guidance based on public comments. Check FDA.gov for the most current information.
State Law Notice: State vaping laws may be stricter than federal regulations. Fourteen+ states have flavor restrictions that exceed FDA policy. Always check local regulations before purchasing or selling vape products.
Content Notice: This content is intended for adults 21+. It addresses regulatory policy and does not promote tobacco or nicotine product use.